157 related articles for article (PubMed ID: 25064349)
1. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
[TBL] [Abstract][Full Text] [Related]
2. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
[TBL] [Abstract][Full Text] [Related]
3. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new pyrazole derivatives and their anticancer evaluation.
Nitulescu GM; Draghici C; Missir AV
Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
[TBL] [Abstract][Full Text] [Related]
7. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
8. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
Zhang D; Wang G; Zhao G; Xu W; Huo L
Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925
[TBL] [Abstract][Full Text] [Related]
19. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents.
Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC
Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]